Specialty Pharmacy

Like so many other conferences and events, ASCO transitioned to an online format because of the coronavirus disease 2019 (COVID-19) outbreak.

Study shows significant genomic differences between tumors caused by different strains of human papillomavirus.

Ozanimod (Zeposia) became the third oral S1P modulator approved by the FDA for the treatment of multiple sclerosis,

The combination of sintilimab, pemetrexed, and a platinum-based chemotherapy has shown promise for nonsquamous non-small cell lung cancer.

Human papillomavirus vaccine may reduce the chance of high-grade cervical intraepithelial neoplasis.

Frontline health care workers have a 3-fold increased risk of contracting coronavirus disease 2019 despite use of personal protective equipment.

Study shows that an individual's response to immunotherapy can be predicted within weeks, based on increasing or decreasing levels of circulating tumor DNA.

By using a non-invasive screening model, care providers can help catch and treat more cases of colorectal cancer, a new study suggests.

Study examines the effect of a low-calorie, plant-based diet combined with vitamin C in helping to kill cancer cells.

Belantamab mafodotin-blmf is the first anti-BCMA therapy approved by the FDA for the treatment of patients with relapsed or refractory multiple myeloma who received at least 4 prior therapies.

Introducing an online PharmD program presents a unique set of challenges for educators.

JD Power 2020 US Pharmacy Study ranks Good Neighbor Pharmacy highest among brick-and-mortar chain drug store pharmacies in customer satisfaction.

Women comprise more than 60% of pharmacy graduates, yet gender gaps still exist in pharmacy ownership, school deanships, and other leadership positions.

With the groundbreaking advancements in specialty pharmacy, it is important to recognize the uniqueness of these medications and their respective patient populations.

Although transfering the annual event to a virtual format presented challenges, NASP President and CEO Sheila Arquette, RPh, said she is excited to connect with attendees just as much as in previous years.

Research may address the lack of effective treatments for mental fatigue among patients with multiple sclerosis.

This year’s annual NASP meeting will feature an enhanced virtual environment that allows attendees to earn required CPE credits, share best practices, and browse a convention hall.

Home infusion of teprotumumab-trbw (Tepezza), a breakthrough treatment for thyroid eye disease, was found to effectively minimize the chance of infection with coronavirus disease 2019 for both patients and staff of Chartwell Pennsylvania, LP.

In the United States, these findings would translate to more than 269,000 prevented breast cancer cases and nearly 44,000 prevented cases of ovarian cancer.

As more Americans identify as LGBTQIA+, an effort needs to made to educate pharmacists on LGBTQIA+ health and culture.

Representatives from the organizations spoke with HHS last week before President Donald Trump signed several executive orders, including one that would address manufacturer rebates also collected by PBMs.

Officials with the FDA have approved atezolizumab plus cobimetinib and vemurafenib for the treatment of patients with BRAF V600 mutation-positive advanced melanoma.

Pharmacists, researchers, and other health care professionals must keep pushing these boundaries to continue advancing the field of medicine and providing effective patient care.

A new study found that it’s safe for patients with HIV to receive HIV-positive kidneys.

Although the treatment of cancer is facing many challenges, the pandemic is also creating massive amounts of new data with which to educate patients, conduct new research, and make more informed clinical decisions.

New research suggests vitamin D can help prevent colitis in those using immune checkpoint inhibitors.

Spinal muscular atrophy is the leading genetic cause of death in infants.

Earlier results of the FAST trial, which was launched in 2004, found that reducing the number of radiotherapy fractions to 5 was feasible and safe in the short term.